Saluvexis organizes its solutions across two axes: distribution by product line (devices, medicines, clinical nutrition) and solutions by audience (public hospitals, private hospitals, international manufacturers).
Each category has specific regulations, adapted storage requirements, and differentiated regulatory expertise. Saluvexis covers the three critical lines of the Costa Rican health sector.
Distribution of class I to IV devices under Decree 34482-S and Health Canada classification, with simplified pathways for products approved by FDA/EMA.
View solution
Distribution of chemical synthesis medicines, biologics, biosimilars, products requiring bioequivalence, and hospital specialties under RTCA and Decree 43259-COMEX-S-MEIC.
View solution
Distribution of enteral and parenteral nutrition products and specialized supplements for hospital and outpatient settings under specific regulations.
View solutionEach client type has different operational, regulatory, and commercial needs. Saluvexis adapts its service model to the buyer or partner profile.
Active supplier of the Costa Rican Social Security Fund (CCSS) participating in SICOP tenders. Comprehensive sanitary compliance and document traceability.
View solution
Direct supply to the Costa Rican private network (CIMA, Hospital Metropolitano, Clínica Bíblica, Hospital La Católica) with traceable delivery and technical support.
View solution
Integrated market entry to Costa Rica under one contract: sanitary registration, legal representation, regulatory pharmacy, and active commercial distribution.
View solutionRegardless of product category or client type, Saluvexis operates under common principles and standards that guarantee consistency, traceability, and compliance.
Let's discuss the solution that best fits your product category or organizational profile.